- Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancerBryan A Faller
Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Clin Med Insights Oncol 5:131-44. 2011..Its safety has been well established with neutropenia, anemia, nausea, and vomiting being the most frequently encountered toxicities. The data defining the risks and benefits of vinorelbine in the treatment of NSCLC will be summarized...
- Images in clinical medicine. New-onset clubbing associated with lung cancerBryan A Faller
Washington University School of Medicine, St Louis, MO 63110, USA
N Engl J Med 359:e15. 2008
- Therapy-related acute myelogenous leukemia with an 11q23/MLL translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancerBryan A Faller
Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
Clin Lung Cancer 10:438-40. 2009..To our knowledge, this is the first case of therapy-related acute myelogenous leukemia (t-AML) associated with this chemotherapy combination. The literature on t-AML with the 11q23/MLL rearrangement is reviewed...